Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mirati Therapeutics Inc (NASDAQ:MRTX)

5.60
Delayed Data
As of 4:00pm ET
 +0.25 / +4.67%
Today’s Change
4.40
Today|||52-Week Range
37.83
-82.28%
Year-to-Date
No recent news for Mirati Therapeutics Inc.

Today’s Trading

Previous close5.35
Today’s open5.35
Day’s range5.28 - 5.70
Volume114,294
Average volume (3 months)217,075
Market cap$106.6M
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)-17.90%
Earnings growth (this year)-9.42%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
OVASOvaScience Inc-0.12-3.99%
GTXIGTX Inc+0.34+5.18%
--Innovative Pharmaceu...+0.00+1.43%
CORICorium International...+0.15+3.23%
Data as of 4:00pm ET, 12/08/2016

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.97
Annual revenue (last year)$0.00
Annual profit (last year)-$64.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles M. Baum
Chief Financial Officer &
Senior Vice President
Jamie A. Donadio
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs